Do analysts prefer SLS or APHA?

Solaris Resources currently has a consensus price target of C$19.50, suggesting a potential upside of 48.85%. Given Solaris Resources' stronger consensus rating and higher possible upside, research analysts plainly believe Solaris Resources is more favorable than Aphria. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Aphria 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is SLS or APHA more profitable?

Solaris Resources' return on equity of 60.97% beat Aphria's return on equity. Company Net Margins Return on Equity Return on Assets Solaris Resources N/A 60.97% -51.67% Aphria N/A N/A N/A

Do analysts recommend SLS or BHC?

Solaris Resources currently has a consensus target price of C$19.50, suggesting a potential upside of 48.85%. Given Solaris Resources' stronger consensus rating and higher possible upside, analysts plainly believe Solaris Resources is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Bausch Health Companies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend SLS or AUP?

Solaris Resources currently has a consensus target price of C$19.50, indicating a potential upside of 48.85%. Given Solaris Resources' stronger consensus rating and higher possible upside, equities analysts clearly believe Solaris Resources is more favorable than Aurinia Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Aurinia Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is SLS or AUP more profitable?

Solaris Resources' return on equity of 60.97% beat Aurinia Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Solaris Resources N/A 60.97% -51.67% Aurinia Pharmaceuticals N/A N/A N/A

Do analysts recommend CARA or SLS?

Solaris Resources has a consensus price target of C$19.50, suggesting a potential upside of 48.85%. Given Solaris Resources' stronger consensus rating and higher possible upside, analysts plainly believe Solaris Resources is more favorable than Cara Operations. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cara Operations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has preferable earnings and valuation, CARA or SLS?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cara Operations N/A N/A N/A N/A N/A Solaris Resources N/A N/A -C$46.49M -C$0.19 N/A

Is CARA or SLS more profitable?

Solaris Resources' return on equity of 60.97% beat Cara Operations' return on equity. Company Net Margins Return on Equity Return on Assets Cara Operations N/A N/A N/A Solaris Resources N/A 60.97% -51.67%

Solaris Resources (SLS) Competitors

C$13.10 0.00 (0.00%)

As of 06/12/2026 04:00 PM Eastern

Compare

SLS vs. APHA, PBH, BHC, AUP, and CARA

Should you buy Solaris Resources stock or one of its competitors? MarketBeat compares Solaris Resources with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Solaris Resources include Aphria (APHA), Premium Brands (PBH), Bausch Health Companies (BHC), Aurinia Pharmaceuticals (AUP), and Cara Operations (CARA). These companies are all part of the "pharmaceutical products" industry.

How does Solaris Resources compare to Aphria?

Solaris Resources (TSE:SLS) and Aphria (TSE:APHA) are both mid-cap pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

In the previous week, Solaris Resources' average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company	Overall Sentiment
Solaris Resources	Neutral
Aphria	Neutral

Solaris Resources currently has a consensus price target of C$19.50, suggesting a potential upside of 48.85%. Given Solaris Resources' stronger consensus rating and higher possible upside, research analysts plainly believe Solaris Resources is more favorable than Aphria.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Aphria	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Solaris Resources has higher earnings, but lower revenue than Aphria. Solaris Resources is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A
Aphria	C$611.06M	0.00	-C$637.39M	-C$2.01	N/A

16.5% of Solaris Resources shares are owned by institutional investors. 40.6% of Solaris Resources shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Solaris Resources' return on equity of 60.97% beat Aphria's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solaris Resources	N/A	60.97%	-51.67%
Aphria	N/A	N/A	N/A

Summary

Solaris Resources beats Aphria on 8 of the 11 factors compared between the two stocks.

How does Solaris Resources compare to Premium Brands?

Solaris Resources (TSE:SLS) and Premium Brands (TSE:PBH) are both mid-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability.

16.5% of Solaris Resources shares are held by institutional investors. Comparatively, 31.7% of Premium Brands shares are held by institutional investors. 40.6% of Solaris Resources shares are held by company insiders. Comparatively, 2.0% of Premium Brands shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Solaris Resources has a beta of 1.721408, indicating that its share price is 72% more volatile than the broader market. Comparatively, Premium Brands has a beta of 0.88205, indicating that its share price is 12% less volatile than the broader market.

Solaris Resources presently has a consensus target price of C$19.50, suggesting a potential upside of 48.85%. Premium Brands has a consensus target price of C$118.62, suggesting a potential upside of 34.61%. Given Solaris Resources' stronger consensus rating and higher probable upside, analysts plainly believe Solaris Resources is more favorable than Premium Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Premium Brands	0 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.92

In the previous week, Premium Brands had 1 more articles in the media than Solaris Resources. MarketBeat recorded 1 mentions for Premium Brands and 0 mentions for Solaris Resources. Solaris Resources' average media sentiment score of 0.00 equaled Premium Brands'average media sentiment score.

Company	Overall Sentiment
Solaris Resources	Neutral
Premium Brands	Neutral

Premium Brands has higher revenue and earnings than Solaris Resources. Solaris Resources is trading at a lower price-to-earnings ratio than Premium Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A
Premium Brands	C$7.88B	0.58	C$99.56M	C$0.90	97.91

Premium Brands has a net margin of 0.52% compared to Solaris Resources' net margin of 0.00%. Solaris Resources' return on equity of 60.97% beat Premium Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solaris Resources	N/A	60.97%	-51.67%
Premium Brands	0.52%	2.21%	3.61%

Summary

Premium Brands beats Solaris Resources on 9 of the 14 factors compared between the two stocks.

How does Solaris Resources compare to Bausch Health Companies?

Solaris Resources (TSE:SLS) and Bausch Health Companies (TSE:BHC) are both mid-cap pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

Solaris Resources has a beta of 1.721408, meaning that its share price is 72% more volatile than the broader market. Comparatively, Bausch Health Companies has a beta of 0.942978, meaning that its share price is 6% less volatile than the broader market.

In the previous week, Solaris Resources' average media sentiment score of 0.00 equaled Bausch Health Companies'average media sentiment score.

Company	Overall Sentiment
Solaris Resources	Neutral
Bausch Health Companies	Neutral

16.5% of Solaris Resources shares are held by institutional investors. Comparatively, 11.0% of Bausch Health Companies shares are held by institutional investors. 40.6% of Solaris Resources shares are held by company insiders. Comparatively, 11.3% of Bausch Health Companies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Solaris Resources has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Solaris Resources' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solaris Resources	N/A	60.97%	-51.67%
Bausch Health Companies	-13.54%	120.43%	4.16%

Solaris Resources currently has a consensus target price of C$19.50, suggesting a potential upside of 48.85%. Given Solaris Resources' stronger consensus rating and higher possible upside, analysts plainly believe Solaris Resources is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Solaris Resources has higher earnings, but lower revenue than Bausch Health Companies. Solaris Resources is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A
Bausch Health Companies	C$10.53B	0.25	-C$125.65M	-C$3.24	N/A

Summary

Solaris Resources beats Bausch Health Companies on 9 of the 13 factors compared between the two stocks.

How does Solaris Resources compare to Aurinia Pharmaceuticals?

Solaris Resources (TSE:SLS) and Aurinia Pharmaceuticals (TSE:AUP) are both mid-cap pharmaceutical products companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

16.5% of Solaris Resources shares are owned by institutional investors. 40.6% of Solaris Resources shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Solaris Resources' average media sentiment score of 0.00 equaled Aurinia Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Solaris Resources	Neutral
Aurinia Pharmaceuticals	Neutral

Solaris Resources currently has a consensus target price of C$19.50, indicating a potential upside of 48.85%. Given Solaris Resources' stronger consensus rating and higher possible upside, equities analysts clearly believe Solaris Resources is more favorable than Aurinia Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Aurinia Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Solaris Resources has higher earnings, but lower revenue than Aurinia Pharmaceuticals. Solaris Resources is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A
Aurinia Pharmaceuticals	C$57.59M	0.00	-C$190.03M	-C$1.48	N/A

Solaris Resources' return on equity of 60.97% beat Aurinia Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solaris Resources	N/A	60.97%	-51.67%
Aurinia Pharmaceuticals	N/A	N/A	N/A

Summary

Solaris Resources beats Aurinia Pharmaceuticals on 8 of the 11 factors compared between the two stocks.

How does Solaris Resources compare to Cara Operations?

Cara Operations (TSE:CARA) and Solaris Resources (TSE:SLS) are both pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cara Operations	N/A	N/A	N/A	N/A	N/A
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A

In the previous week, Cara Operations' average media sentiment score of 0.00 equaled Solaris Resources'average media sentiment score.

Company	Overall Sentiment
Cara Operations	Neutral
Solaris Resources	Neutral

16.5% of Solaris Resources shares are held by institutional investors. 40.6% of Solaris Resources shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Solaris Resources' return on equity of 60.97% beat Cara Operations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cara Operations	N/A	N/A	N/A
Solaris Resources	N/A	60.97%	-51.67%

Solaris Resources has a consensus price target of C$19.50, suggesting a potential upside of 48.85%. Given Solaris Resources' stronger consensus rating and higher possible upside, analysts plainly believe Solaris Resources is more favorable than Cara Operations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cara Operations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Solaris Resources beats Cara Operations on 6 of the 7 factors compared between the two stocks.

Get Solaris Resources News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SLS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SLS vs. The Competition

Export

Metric	Solaris Resources	Other Precious Metals & Mining Industry	Materials Sector	TSE Exchange
Market Cap	C$2.19B	C$635.17M	C$4.80B	C$12.19B
Dividend Yield	N/A	6.08%	4.99%	6.19%
P/E Ratio	-68.95	12.96	23.20	36.94
Price / Sales	N/A	3,705.03	6,087.02	10.45
Price / Cash	64.53	13.04	24.28	82.29
Price / Book	-43.43	59.03	9.06	4.47
Net Income	-C$46.49M	-C$4.87M	C$156.77M	C$299.09M
7 Day Performance	6.94%	1.08%	0.65%	0.65%
1 Month Performance	-3.96%	-10.06%	-3.61%	-0.08%
1 Year Performance	108.60%	63.23%	57.49%	41.90%

Solaris Resources Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SLS Solaris Resources	1.477 of 5 stars	C$13.10 flat	C$19.50 +48.9%	+108.6%	C$2.19B	N/A	N/A	10	Gap Down
APHA Aphria	N/A	N/A	N/A	N/A	C$5.24B	C$611.06M	N/A	1,200
PBH Premium Brands	3.2926 of 5 stars	C$87.96 -3.8%	C$118.62 +34.9%	+10.6%	C$4.57B	C$7.88B	97.73	540	High Trading Volume
BHC Bausch Health Companies	0.3508 of 5 stars	C$7.32 +6.1%	N/A	-12.7%	C$2.73B	C$10.53B	N/A	19,900
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A	C$2.15B	C$57.59M	N/A	300	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:SLS) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Solaris Resources (SLS) Competitors

SLS vs. APHA, PBH, BHC, AUP, and CARA

How does Solaris Resources compare to Aphria?

Summary

How does Solaris Resources compare to Premium Brands?

Summary

How does Solaris Resources compare to Bausch Health Companies?

Summary

How does Solaris Resources compare to Aurinia Pharmaceuticals?

Summary

How does Solaris Resources compare to Cara Operations?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SLS vs. The Competition

Solaris Resources Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Solaris Resources (SLS) Competitors

SLS vs. APHA, PBH, BHC, AUP, and CARA

How does Solaris Resources compare to Aphria?

Does the media prefer SLS or APHA?

Do analysts prefer SLS or APHA?

Which has better valuation & earnings, SLS or APHA?

Do institutionals and insiders hold more shares of SLS or APHA?

Is SLS or APHA more profitable?

Summary

How does Solaris Resources compare to Premium Brands?

Do institutionals and insiders believe in SLS or PBH?

Which has more risk & volatility, SLS or PBH?

Do analysts rate SLS or PBH?

Does the media favor SLS or PBH?

Which has better earnings & valuation, SLS or PBH?

Is SLS or PBH more profitable?

Summary

How does Solaris Resources compare to Bausch Health Companies?

Which has more volatility and risk, SLS or BHC?

Does the media prefer SLS or BHC?

Do institutionals and insiders hold more shares of SLS or BHC?

Is SLS or BHC more profitable?

Do analysts recommend SLS or BHC?

Which has better earnings and valuation, SLS or BHC?

Summary

How does Solaris Resources compare to Aurinia Pharmaceuticals?

Do institutionals & insiders have more ownership in SLS or AUP?

Does the media refer more to SLS or AUP?

Do analysts recommend SLS or AUP?

Which has preferable earnings and valuation, SLS or AUP?

Is SLS or AUP more profitable?

Summary

How does Solaris Resources compare to Cara Operations?

Which has preferable earnings and valuation, CARA or SLS?

Does the media favor CARA or SLS?

Do institutionals and insiders believe in CARA or SLS?

Is CARA or SLS more profitable?

Do analysts recommend CARA or SLS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SLS vs. The Competition

Solaris Resources Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools